Rankin Aubrey

Rankin Aubrey's trades of Revance Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2021-12-06 2021-12-03 B Purchase
30,000 +45.8%
14.43
USD 432,876
30,000 +45.8% 14.43 USD 432,876
2021-04-06 2021-04-05 PS Planned sale
2 -0.0%
28.28
USD 57
2 -0.0% 28.28 USD 57
2021-03-05 2021-03-04 PS Planned sale
33,119 -7.5%
25.43
USD 842,216
33,119 -7.5% 25.43 USD 842,216
2021-02-03 2021-02-01 PS Planned sale
33,119 -6.9%
25.95
USD 859,438
33,119 -6.9% 25.95 USD 859,438
2021-01-04 2020-12-30 PS Planned sale
33,119 -6.5%
27.82
USD 921,212
33,119 -6.5% 27.82 USD 921,212
2020-12-02 2020-11-30 PS Planned sale
33,119 -6.1%
23.85
USD 789,888
33,119 -6.1% 23.85 USD 789,888
2020-10-30 2020-10-29 PS Planned sale
33,119 -5.7%
26.15
USD 865,949
33,119 -5.7% 26.15 USD 865,949
// ... existing code ... // ... rest of the file ...